446 related articles for article (PubMed ID: 29667436)
1. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
Khoruts A
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):435-438. PubMed ID: 29667436
[No Abstract] [Full Text] [Related]
2. Novel approaches to treating Clostridium difficile-associated colitis.
Padua D; Pothoulakis C
Expert Rev Gastroenterol Hepatol; 2016; 10(2):193-204. PubMed ID: 26643655
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Hvas CL; Dahl Jørgensen SM; Jørgensen SP; Storgaard M; Lemming L; Hansen MM; Erikstrup C; Dahlerup JF
Gastroenterology; 2019 Apr; 156(5):1324-1332.e3. PubMed ID: 30610862
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
Tan X; Johnson S
Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
[TBL] [Abstract][Full Text] [Related]
6. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
8. New and emerging therapies in treatment of Clostridium difficile infection.
Goyal H; Perisetti A; Rehman MR; Singla U
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
[TBL] [Abstract][Full Text] [Related]
9. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
[TBL] [Abstract][Full Text] [Related]
10. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplant for C. difficile infection: Just say yes.
Cammarota G; Gallo A; Bibbò S
Anaerobe; 2019 Dec; 60():102109. PubMed ID: 31644957
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Carlucci C; Petrof EO; Allen-Vercoe E
EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Leung V; Vincent C; Edens TJ; Miller M; Manges AR
Clin Infect Dis; 2018 Jan; 66(3):456-457. PubMed ID: 29020222
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
Merlo G; Graves N; Brain D; Connelly LB
J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242
[TBL] [Abstract][Full Text] [Related]
15. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
Tang G; Yin W; Liu W
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
[TBL] [Abstract][Full Text] [Related]
16. Current applications of fecal microbiota transplantation in intestinal disorders.
Hsu WH; Wang JY; Kuo CH
Kaohsiung J Med Sci; 2019 Jun; 35(6):327-331. PubMed ID: 31017741
[TBL] [Abstract][Full Text] [Related]
17. Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
Diamond C; McNeilly T
Ulster Med J; 2017 May; 86(2):108-110. PubMed ID: 29535482
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series.
Bamba S; Nishida A; Imaeda H; Inatomi O; Sasaki M; Sugimoto M; Andoh A
J Microbiol Immunol Infect; 2019 Aug; 52(4):663-666. PubMed ID: 29158082
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota Transplantation.
Vindigni SM; Surawicz CM
Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
